0001209191-24-001302.txt : 20240109
0001209191-24-001302.hdr.sgml : 20240109
20240109193528
ACCESSION NUMBER: 0001209191-24-001302
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shukla Sanjay
CENTRAL INDEX KEY: 0001671026
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 24524583
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 10240 SORRENTO VALLEY ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8587318389
MAIL ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-05
0
0001339970
aTYR PHARMA INC
LIFE
0001671026
Shukla Sanjay
10240 SORRENTO VALLEY ROAD
SUITE 300
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
0
Employee Stock Option (right to buy)
1.50
2024-01-05
4
A
0
600000
0.00
A
2034-01-05
Common Stock
600000
600000
D
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 5, 2024, such that this option will be fully exercisable on January 5, 2028. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
/s/ Nancy E. Denyes, attorney-in-fact
2024-01-09